

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.27201097 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.27201097 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.96231229 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.96231229 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.61266280 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.14405066 |
| 7 | tryptophan catabolic process (GO:0006569) | 6.03077066 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 6.03077066 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 6.03077066 |
| 10 | kynurenine metabolic process (GO:0070189) | 5.94938905 |
| 11 | urea metabolic process (GO:0019627) | 5.83324379 |
| 12 | urea cycle (GO:0000050) | 5.83324379 |
| 13 | bile acid biosynthetic process (GO:0006699) | 5.82279068 |
| 14 | tryptophan metabolic process (GO:0006568) | 5.69340895 |
| 15 | glyoxylate metabolic process (GO:0046487) | 5.58975881 |
| 16 | negative regulation of fibrinolysis (GO:0051918) | 5.58241223 |
| 17 | alpha-linolenic acid metabolic process (GO:0036109) | 5.56881541 |
| 18 | protein carboxylation (GO:0018214) | 5.52327774 |
| 19 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.52327774 |
| 20 | high-density lipoprotein particle remodeling (GO:0034375) | 5.45712251 |
| 21 | regulation of protein activation cascade (GO:2000257) | 5.43084444 |
| 22 | complement activation, alternative pathway (GO:0006957) | 5.39065960 |
| 23 | regulation of fibrinolysis (GO:0051917) | 5.38461180 |
| 24 | nitrogen cycle metabolic process (GO:0071941) | 5.30164932 |
| 25 | regulation of vitamin D biosynthetic process (GO:0060556) | 5.21855988 |
| 26 | regulation of T-helper 1 cell differentiation (GO:0045625) | 5.20762445 |
| 27 | cysteine metabolic process (GO:0006534) | 5.17699128 |
| 28 | sulfur amino acid catabolic process (GO:0000098) | 5.12439777 |
| 29 | regulation of complement activation (GO:0030449) | 5.07788883 |
| 30 | serine family amino acid catabolic process (GO:0009071) | 4.99962502 |
| 31 | bile acid metabolic process (GO:0008206) | 4.95325246 |
| 32 | reverse cholesterol transport (GO:0043691) | 4.79156993 |
| 33 | aromatic amino acid family metabolic process (GO:0009072) | 4.76987807 |
| 34 | regulation of triglyceride catabolic process (GO:0010896) | 4.73043994 |
| 35 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.72814725 |
| 36 | homocysteine metabolic process (GO:0050667) | 4.70482337 |
| 37 | regulation of cytokine secretion involved in immune response (GO:0002739) | 4.68771186 |
| 38 | macromolecular complex remodeling (GO:0034367) | 4.67939416 |
| 39 | plasma lipoprotein particle remodeling (GO:0034369) | 4.67939416 |
| 40 | protein-lipid complex remodeling (GO:0034368) | 4.67939416 |
| 41 | regulation of cholesterol esterification (GO:0010872) | 4.67374485 |
| 42 | regulation of chronic inflammatory response (GO:0002676) | 4.65686794 |
| 43 | regulation of fever generation (GO:0031620) | 4.63295171 |
| 44 | acylglycerol homeostasis (GO:0055090) | 4.58279596 |
| 45 | triglyceride homeostasis (GO:0070328) | 4.58279596 |
| 46 | tyrosine metabolic process (GO:0006570) | 4.58264232 |
| 47 | phospholipid efflux (GO:0033700) | 4.56855044 |
| 48 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 4.55213184 |
| 49 | negative regulation of sterol transport (GO:0032372) | 4.54348812 |
| 50 | negative regulation of cholesterol transport (GO:0032375) | 4.54348812 |
| 51 | amino-acid betaine metabolic process (GO:0006577) | 4.50539796 |
| 52 | positive regulation of heat generation (GO:0031652) | 4.50527102 |
| 53 | alpha-amino acid catabolic process (GO:1901606) | 4.46038977 |
| 54 | lysine catabolic process (GO:0006554) | 4.36363960 |
| 55 | lysine metabolic process (GO:0006553) | 4.36363960 |
| 56 | plasma lipoprotein particle clearance (GO:0034381) | 4.33541418 |
| 57 | glycine metabolic process (GO:0006544) | 4.32133993 |
| 58 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.31795685 |
| 59 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.30589403 |
| 60 | bile acid and bile salt transport (GO:0015721) | 4.29217069 |
| 61 | regulation of interferon-alpha production (GO:0032647) | 4.29102352 |
| 62 | imidazole-containing compound metabolic process (GO:0052803) | 4.27511794 |
| 63 | cholesterol efflux (GO:0033344) | 4.22245257 |
| 64 | indolalkylamine metabolic process (GO:0006586) | 4.21559240 |
| 65 | cellular glucuronidation (GO:0052695) | 4.15338145 |
| 66 | fibrinolysis (GO:0042730) | 4.14664213 |
| 67 | amine catabolic process (GO:0009310) | 4.13663422 |
| 68 | cellular biogenic amine catabolic process (GO:0042402) | 4.13663422 |
| 69 | cellular amino acid catabolic process (GO:0009063) | 4.06663752 |
| 70 | coenzyme catabolic process (GO:0009109) | 4.05232587 |
| 71 | cellular ketone body metabolic process (GO:0046950) | 4.02749203 |
| 72 | glutamate metabolic process (GO:0006536) | 4.02667301 |
| 73 | serine family amino acid metabolic process (GO:0009069) | 4.02451588 |
| 74 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.98841547 |
| 75 | arginine metabolic process (GO:0006525) | 3.97780036 |
| 76 | benzene-containing compound metabolic process (GO:0042537) | 3.96869442 |
| 77 | plasma lipoprotein particle assembly (GO:0034377) | 3.95792097 |
| 78 | ethanol oxidation (GO:0006069) | 3.95467926 |
| 79 | cellular modified amino acid catabolic process (GO:0042219) | 3.94892295 |
| 80 | regulation of vitamin metabolic process (GO:0030656) | 3.94491612 |
| 81 | negative regulation of interleukin-12 production (GO:0032695) | 3.87635631 |
| 82 | regulation of cholesterol homeostasis (GO:2000188) | 3.87601181 |
| 83 | low-density lipoprotein particle remodeling (GO:0034374) | 3.87184891 |
| 84 | serine family amino acid biosynthetic process (GO:0009070) | 3.84900746 |
| 85 | phospholipid homeostasis (GO:0055091) | 3.82439641 |
| 86 | positive regulation of lipid catabolic process (GO:0050996) | 3.79672686 |
| 87 | regulation of chemokine biosynthetic process (GO:0045073) | 3.79611460 |
| 88 | regulation of heat generation (GO:0031650) | 3.78448002 |
| 89 | regulation of bile acid biosynthetic process (GO:0070857) | 3.78364427 |
| 90 | cytolysis (GO:0019835) | 3.71657565 |
| 91 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.71332968 |
| 92 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.71332968 |
| 93 | aldehyde catabolic process (GO:0046185) | 3.70940494 |
| 94 | complement activation, classical pathway (GO:0006958) | 3.70467275 |
| 95 | cholesterol homeostasis (GO:0042632) | 3.68931704 |
| 96 | complement activation (GO:0006956) | 3.68453065 |
| 97 | blood coagulation, intrinsic pathway (GO:0007597) | 3.68123184 |
| 98 | glucuronate metabolic process (GO:0019585) | 3.66937048 |
| 99 | uronic acid metabolic process (GO:0006063) | 3.66937048 |
| 100 | protein activation cascade (GO:0072376) | 3.65652186 |
| 101 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.65463457 |
| 102 | negative regulation of lipase activity (GO:0060192) | 3.64258133 |
| 103 | sterol homeostasis (GO:0055092) | 3.63324589 |
| 104 | drug catabolic process (GO:0042737) | 3.62124864 |
| 105 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.61413393 |
| 106 | plasma lipoprotein particle organization (GO:0071827) | 3.58357797 |
| 107 | acute-phase response (GO:0006953) | 3.56419862 |
| 108 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.54937461 |
| 109 | positive regulation of interferon-alpha production (GO:0032727) | 3.54011922 |
| 110 | protein-lipid complex assembly (GO:0065005) | 3.53881621 |
| 111 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.53664309 |
| 112 | organic acid catabolic process (GO:0016054) | 3.52464123 |
| 113 | carboxylic acid catabolic process (GO:0046395) | 3.52464123 |
| 114 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.51507144 |
| 115 | cofactor catabolic process (GO:0051187) | 3.51002915 |
| 116 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.49530536 |
| 117 | acetyl-CoA metabolic process (GO:0006084) | 3.48825477 |
| 118 | regulation of plasminogen activation (GO:0010755) | 3.45740108 |
| 119 | intestinal cholesterol absorption (GO:0030299) | 3.45701416 |
| 120 | cellular response to ATP (GO:0071318) | 3.44624641 |
| 121 | positive regulation of defense response to virus by host (GO:0002230) | 3.34516698 |
| 122 | regulation of mononuclear cell migration (GO:0071675) | 3.12492396 |
| 123 | negative regulation of viral genome replication (GO:0045071) | 3.11819647 |
| 124 | regulation of T-helper 1 type immune response (GO:0002825) | 3.11088514 |
| 125 | positive regulation of T-helper 1 type immune response (GO:0002827) | 3.08417240 |
| 126 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.07928071 |
| 127 | negative regulation of systemic arterial blood pressure (GO:0003085) | 3.04005396 |
| 128 | positive regulation of prostaglandin secretion (GO:0032308) | 3.03354223 |
| 129 | regulation of podosome assembly (GO:0071801) | 3.01728788 |
| 130 | positive regulation of interferon-beta production (GO:0032728) | 3.00692193 |
| 131 | type I interferon signaling pathway (GO:0060337) | 2.98215279 |
| 132 | cellular response to type I interferon (GO:0071357) | 2.98215279 |
| 133 | regulation of immunoglobulin secretion (GO:0051023) | 2.95879150 |
| 134 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.95567511 |
| 135 | response to type I interferon (GO:0034340) | 2.94656545 |
| 136 | regulation of prostaglandin secretion (GO:0032306) | 2.93224533 |
| 137 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.89395667 |
| 138 | negative regulation of lipid storage (GO:0010888) | 2.88171035 |
| 139 | eosinophil chemotaxis (GO:0048245) | 2.85457458 |
| 140 | response to peptidoglycan (GO:0032494) | 2.83467094 |
| 141 | response to ATP (GO:0033198) | 2.82078289 |
| 142 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.80859744 |
| 143 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.80822124 |
| 144 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.79161133 |
| 145 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.78120365 |
| 146 | DNA deamination (GO:0045006) | 2.77919138 |
| 147 | regulation of T-helper cell differentiation (GO:0045622) | 2.75884009 |
| 148 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.75207976 |
| 149 | interferon-gamma production (GO:0032609) | 2.73046457 |
| 150 | vitamin biosynthetic process (GO:0009110) | 2.72667184 |
| 151 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.72331654 |
| 152 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.71432166 |
| 153 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.71064521 |
| 154 | regulation of nitric oxide biosynthetic process (GO:0045428) | 2.68874137 |
| 155 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.68614416 |
| 156 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.68548236 |
| 157 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.68409012 |
| 158 | positive regulation of calcium ion import (GO:0090280) | 2.67831224 |
| 159 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.66659408 |
| 160 | response to interferon-beta (GO:0035456) | 2.65861022 |
| 161 | regulation of NF-kappaB import into nucleus (GO:0042345) | 2.61901834 |
| 162 | regulation of interleukin-12 production (GO:0032655) | 2.61825788 |
| 163 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.60043653 |
| 164 | positive regulation of acute inflammatory response (GO:0002675) | 2.57422378 |
| 165 | positive regulation of interleukin-12 production (GO:0032735) | 2.57260938 |
| 166 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.54824942 |
| 167 | monocyte chemotaxis (GO:0002548) | 2.54287881 |
| 168 | vasodilation (GO:0042311) | 2.50352963 |
| 169 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.49766857 |
| 170 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.49401528 |
| 171 | cellular response to exogenous dsRNA (GO:0071360) | 2.49354833 |
| 172 | positive regulation of chemokine production (GO:0032722) | 2.49109501 |
| 173 | vitamin D metabolic process (GO:0042359) | 2.48872420 |
| 174 | eosinophil migration (GO:0072677) | 2.48524921 |
| 175 | regulation of defense response to virus by host (GO:0050691) | 2.47197813 |
| 176 | indole-containing compound metabolic process (GO:0042430) | 2.46011530 |
| 177 | cellular response to lipopolysaccharide (GO:0071222) | 2.43875356 |
| 178 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.41450921 |
| 179 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.40592453 |
| 180 | T-helper 1 type immune response (GO:0042088) | 2.40280420 |
| 181 | sphingosine metabolic process (GO:0006670) | 2.40276010 |
| 182 | platelet dense granule organization (GO:0060155) | 2.38968825 |
| 183 | cellular response to molecule of bacterial origin (GO:0071219) | 2.36009651 |
| 184 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.35959489 |
| 185 | positive regulation of protein autophosphorylation (GO:0031954) | 2.35909937 |
| 186 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.35693869 |
| 187 | defense response to protozoan (GO:0042832) | 2.34468158 |
| 188 | sulfation (GO:0051923) | 2.34204163 |
| 189 | positive regulation of interferon-gamma production (GO:0032729) | 2.33274999 |
| 190 | regulation of vascular endothelial growth factor production (GO:0010574) | 2.33261863 |
| 191 | regulation of regulatory T cell differentiation (GO:0045589) | 2.32852580 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.13173722 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.03887341 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.60930445 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.32670859 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.14845101 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.75517852 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.51628405 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.04141731 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.65413987 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.63661346 |
| 11 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.51900997 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.76152883 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.65973878 |
| 14 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.41798179 |
| 15 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.34908758 |
| 16 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.32860638 |
| 17 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.24002561 |
| 18 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.23285240 |
| 19 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.19356569 |
| 20 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.06245042 |
| 21 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.04445428 |
| 22 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.4868539 |
| 23 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.95888359 |
| 24 | VDR_22108803_ChIP-Seq_LS180_Human | 1.93348164 |
| 25 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.91806312 |
| 26 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.89277677 |
| 27 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.86981223 |
| 28 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.86754640 |
| 29 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.80496100 |
| 30 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.73573822 |
| 31 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.66877006 |
| 32 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.65949993 |
| 33 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.63504388 |
| 34 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.62191573 |
| 35 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.58787575 |
| 36 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.58473613 |
| 37 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.56379891 |
| 38 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.54912308 |
| 39 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.54772781 |
| 40 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.53935384 |
| 41 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.52801002 |
| 42 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.52012077 |
| 43 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.49244616 |
| 44 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.44214601 |
| 45 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.42703413 |
| 46 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.41335968 |
| 47 | EWS_26573619_Chip-Seq_HEK293_Human | 1.40990179 |
| 48 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.40728708 |
| 49 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.40535669 |
| 50 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.38922324 |
| 51 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.37179933 |
| 52 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.36282568 |
| 53 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.35460684 |
| 54 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.34891584 |
| 55 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.34353513 |
| 56 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.34017320 |
| 57 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.33273524 |
| 58 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.32040240 |
| 59 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 1.30231814 |
| 60 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 1.30231814 |
| 61 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.28530089 |
| 62 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.26175131 |
| 63 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.25101407 |
| 64 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.24671429 |
| 65 | FUS_26573619_Chip-Seq_HEK293_Human | 1.23580365 |
| 66 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.23073817 |
| 67 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.21425308 |
| 68 | GATA1_22025678_ChIP-Seq_K562_Human | 1.20400428 |
| 69 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.18538394 |
| 70 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.18495941 |
| 71 | GATA3_26560356_Chip-Seq_TH2_Human | 1.18160763 |
| 72 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.17972871 |
| 73 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.17430841 |
| 74 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.16621346 |
| 75 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.16180738 |
| 76 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.14838815 |
| 77 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.14054753 |
| 78 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.13944863 |
| 79 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.13301139 |
| 80 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.12957845 |
| 81 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.12816769 |
| 82 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.12245731 |
| 83 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.12217908 |
| 84 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.10920564 |
| 85 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.10920564 |
| 86 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.10852370 |
| 87 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.10530418 |
| 88 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.10411184 |
| 89 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.09656049 |
| 90 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09508631 |
| 91 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.08919566 |
| 92 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.08358584 |
| 93 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.08328707 |
| 94 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.08162117 |
| 95 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.08156276 |
| 96 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.07827591 |
| 97 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.07456707 |
| 98 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.07386958 |
| 99 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.07256506 |
| 100 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07050052 |
| 101 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.06806507 |
| 102 | CJUN_26792858_Chip-Seq_BT549_Human | 1.06019563 |
| 103 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.05753000 |
| 104 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.03799042 |
| 105 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.03692459 |
| 106 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.03537753 |
| 107 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.03143062 |
| 108 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.02952929 |
| 109 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.02952929 |
| 110 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.02658794 |
| 111 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.02123258 |
| 112 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.01960826 |
| 113 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.01423412 |
| 114 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.00740146 |
| 115 | AR_25329375_ChIP-Seq_VCAP_Human | 1.00726928 |
| 116 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.97165503 |
| 117 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.95501828 |
| 118 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.95142472 |
| 119 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.90775733 |
| 120 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.87205301 |
| 121 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.87097279 |
| 122 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.86959252 |
| 123 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.86897016 |
| 124 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.85601676 |
| 125 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.83808826 |
| 126 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.81946731 |
| 127 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.81298531 |
| 128 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.73111337 |
| 129 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.72328729 |
| 130 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.72026570 |
| 131 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.70660631 |
| 132 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.69948791 |
| 133 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.68877650 |
| 134 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.68190940 |
| 135 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.68177252 |
| 136 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.67908378 |
| 137 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.67812813 |
| 138 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.67714659 |
| 139 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.65738591 |
| 140 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.65266891 |
| 141 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.65266891 |
| 142 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.65140401 |
| 143 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.64804238 |
| 144 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.64717269 |
| 145 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.64561035 |
| 146 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.63535388 |
| 147 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.63406207 |
| 148 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.61446405 |
| 149 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.58404725 |
| 150 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.55467838 |
| 151 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.52186665 |
| 152 | AR_20517297_ChIP-Seq_VCAP_Human | 0.52173057 |
| 153 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.51582785 |
| 154 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.51253169 |
| 155 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.50098136 |
| 156 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.49994284 |
| 157 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.49948802 |
| 158 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.49913472 |
| 159 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.49646205 |
| 160 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.49606366 |
| 161 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.49156447 |
| 162 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.48017507 |
| 163 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.47497151 |
| 164 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.46119949 |
| 165 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.45876655 |
| 166 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.45360571 |
| 167 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.45299994 |
| 168 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.44385541 |
| 169 | * STAT1_17558387_ChIP-Seq_HELA_Human | 0.44312539 |
| 170 | GATA2_19941826_ChIP-Seq_K562_Human | 0.44260776 |
| 171 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.43773752 |
| 172 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.42575315 |
| 173 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.41482226 |
| 174 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.41417710 |
| 175 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.41030213 |
| 176 | CBP_21632823_ChIP-Seq_H3396_Human | 0.40516067 |
| 177 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.40482107 |
| 178 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.39844049 |
| 179 | * STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.38454119 |
| 180 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.38007544 |
| 181 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.37606049 |
| 182 | GATA1_19941826_ChIP-Seq_K562_Human | 0.37569347 |
| 183 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.37507937 |
| 184 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.37236515 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.78152567 |
| 2 | MP0005360_urolithiasis | 7.02760811 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.21473355 |
| 4 | MP0005365_abnormal_bile_salt | 5.98554102 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.69751879 |
| 6 | MP0006054_spinal_hemorrhage | 4.65924220 |
| 7 | MP0003252_abnormal_bile_duct | 3.81968017 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 3.73126157 |
| 9 | MP0003303_peritoneal_inflammation | 3.44774051 |
| 10 | MP0010329_abnormal_lipoprotein_level | 3.36496344 |
| 11 | MP0005083_abnormal_biliary_tract | 3.20197359 |
| 12 | MP0009785_altered_susceptibility_to | 3.17588342 |
| 13 | MP0009840_abnormal_foam_cell | 3.09678302 |
| 14 | MP0002148_abnormal_hypersensitivity_rea | 3.06395060 |
| 15 | MP0005671_abnormal_response_to | 2.80627098 |
| 16 | MP0003011_delayed_dark_adaptation | 2.69567526 |
| 17 | MP0001666_abnormal_nutrient_absorption | 2.66922980 |
| 18 | MP0005332_abnormal_amino_acid | 2.55016044 |
| 19 | MP0003195_calcinosis | 2.51525764 |
| 20 | MP0004510_myositis | 2.47806425 |
| 21 | MP0004019_abnormal_vitamin_homeostasis | 2.25312037 |
| 22 | MP0001835_abnormal_antigen_presentation | 2.23301120 |
| 23 | MP0002837_dystrophic_cardiac_calcinosis | 2.16370830 |
| 24 | MP0000609_abnormal_liver_physiology | 2.13723167 |
| 25 | MP0005000_abnormal_immune_tolerance | 2.13372433 |
| 26 | MP0002138_abnormal_hepatobiliary_system | 2.12108823 |
| 27 | MP0003191_abnormal_cellular_cholesterol | 2.08545134 |
| 28 | MP0001790_abnormal_immune_system | 2.02378701 |
| 29 | MP0005387_immune_system_phenotype | 2.02378701 |
| 30 | MP0002118_abnormal_lipid_homeostasis | 1.93087657 |
| 31 | MP0002254_reproductive_system_inflammat | 1.89499143 |
| 32 | MP0005167_abnormal_blood-brain_barrier | 1.88395158 |
| 33 | MP0001533_abnormal_skeleton_physiology | 1.88274159 |
| 34 | MP0001764_abnormal_homeostasis | 1.81707989 |
| 35 | MP0003868_abnormal_feces_composition | 1.81552576 |
| 36 | MP0002419_abnormal_innate_immunity | 1.79368131 |
| 37 | MP0005319_abnormal_enzyme/_coenzyme | 1.72907473 |
| 38 | MP0005025_abnormal_response_to | 1.71418266 |
| 39 | MP0003646_muscle_fatigue | 1.62129925 |
| 40 | MP0003705_abnormal_hypodermis_morpholog | 1.61514143 |
| 41 | MP0003075_altered_response_to | 1.59069212 |
| 42 | MP0002723_abnormal_immune_serum | 1.58170622 |
| 43 | MP0008004_abnormal_stomach_pH | 1.55405224 |
| 44 | MP0001800_abnormal_humoral_immune | 1.53367409 |
| 45 | MP0002452_abnormal_antigen_presenting | 1.52238711 |
| 46 | MP0006072_abnormal_retinal_apoptosis | 1.44948346 |
| 47 | MP0009697_abnormal_copulation | 1.39473271 |
| 48 | MP0005451_abnormal_body_composition | 1.37116632 |
| 49 | MP0002332_abnormal_exercise_endurance | 1.35670523 |
| 50 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.32220267 |
| 51 | MP0005058_abnormal_lysosome_morphology | 1.28028272 |
| 52 | MP0000343_altered_response_to | 1.26894898 |
| 53 | MP0003172_abnormal_lysosome_physiology | 1.25939389 |
| 54 | MP0002405_respiratory_system_inflammati | 1.23367478 |
| 55 | MP0009643_abnormal_urine_homeostasis | 1.22134790 |
| 56 | MP0010368_abnormal_lymphatic_system | 1.19000283 |
| 57 | MP0000598_abnormal_liver_morphology | 1.16824432 |
| 58 | MP0005647_abnormal_sex_gland | 1.16363368 |
| 59 | MP0010155_abnormal_intestine_physiology | 1.14358284 |
| 60 | MP0001819_abnormal_immune_cell | 1.13617695 |
| 61 | MP0001542_abnormal_bone_strength | 1.13616865 |
| 62 | MP0002277_abnormal_respiratory_mucosa | 1.13444554 |
| 63 | MP0002420_abnormal_adaptive_immunity | 1.12052890 |
| 64 | MP0002295_abnormal_pulmonary_circulatio | 1.11950816 |
| 65 | MP0002163_abnormal_gland_morphology | 1.11936297 |
| 66 | MP0005310_abnormal_salivary_gland | 1.10289601 |
| 67 | MP0009053_abnormal_anal_canal | 1.10095733 |
| 68 | MP0009764_decreased_sensitivity_to | 1.08885036 |
| 69 | MP0003186_abnormal_redox_activity | 1.08346041 |
| 70 | MP0005379_endocrine/exocrine_gland_phen | 1.08099118 |
| 71 | MP0005551_abnormal_eye_electrophysiolog | 1.07966788 |
| 72 | MP0009763_increased_sensitivity_to | 1.02539911 |
| 73 | MP0002998_abnormal_bone_remodeling | 0.99362951 |
| 74 | MP0002933_joint_inflammation | 0.99267730 |
| 75 | MP0003656_abnormal_erythrocyte_physiolo | 0.98890843 |
| 76 | MP0005595_abnormal_vascular_smooth | 0.98502008 |
| 77 | MP0001501_abnormal_sleep_pattern | 0.98304068 |
| 78 | MP0003448_altered_tumor_morphology | 0.96269601 |
| 79 | MP0000516_abnormal_urinary_system | 0.92087795 |
| 80 | MP0005367_renal/urinary_system_phenotyp | 0.92087795 |
| 81 | MP0008469_abnormal_protein_level | 0.91430003 |
| 82 | MP0000604_amyloidosis | 0.91214231 |
| 83 | MP0009780_abnormal_chondrocyte_physiolo | 0.88171104 |
| 84 | MP0005390_skeleton_phenotype | 0.87490513 |
| 85 | MP0001919_abnormal_reproductive_system | 0.86939839 |
| 86 | MP0009278_abnormal_bone_marrow | 0.85238799 |
| 87 | MP0003279_aneurysm | 0.84640401 |
| 88 | MP0005220_abnormal_exocrine_pancreas | 0.84481703 |
| 89 | MP0003950_abnormal_plasma_membrane | 0.82631482 |
| 90 | MP0005389_reproductive_system_phenotype | 0.81455826 |
| 91 | MP0001545_abnormal_hematopoietic_system | 0.79492567 |
| 92 | MP0005397_hematopoietic_system_phenotyp | 0.79492567 |
| 93 | MP0009765_abnormal_xenobiotic_induced | 0.79292103 |
| 94 | MP0005408_hypopigmentation | 0.79278965 |
| 95 | MP0002876_abnormal_thyroid_physiology | 0.78023850 |
| 96 | MP0009642_abnormal_blood_homeostasis | 0.77871951 |
| 97 | MP0005164_abnormal_response_to | 0.76998187 |
| 98 | MP0003436_decreased_susceptibility_to | 0.76404434 |
| 99 | MP0009333_abnormal_splenocyte_physiolog | 0.74279012 |
| 100 | MP0002693_abnormal_pancreas_physiology | 0.73212006 |
| 101 | MP0005376_homeostasis/metabolism_phenot | 0.72910409 |
| 102 | MP0001661_extended_life_span | 0.72333514 |
| 103 | MP0005636_abnormal_mineral_homeostasis | 0.72015831 |
| 104 | MP0005084_abnormal_gallbladder_morpholo | 0.70909705 |
| 105 | MP0005248_abnormal_Harderian_gland | 0.69476805 |
| 106 | MP0000716_abnormal_immune_system | 0.69465097 |
| 107 | MP0002653_abnormal_ependyma_morphology | 0.68870907 |
| 108 | MP0002971_abnormal_brown_adipose | 0.66635761 |
| 109 | MP0004381_abnormal_hair_follicle | 0.66429073 |
| 110 | MP0004133_heterotaxia | 0.66298012 |
| 111 | MP0005334_abnormal_fat_pad | 0.65489410 |
| 112 | MP0005670_abnormal_white_adipose | 0.65451620 |
| 113 | MP0001485_abnormal_pinna_reflex | 0.64388040 |
| 114 | MP0002796_impaired_skin_barrier | 0.63403740 |
| 115 | MP0000767_abnormal_smooth_muscle | 0.62772937 |
| 116 | MP0002078_abnormal_glucose_homeostasis | 0.62672554 |
| 117 | MP0000230_abnormal_systemic_arterial | 0.62446886 |
| 118 | MP0001756_abnormal_urination | 0.61972931 |
| 119 | MP0006082_CNS_inflammation | 0.61215744 |
| 120 | MP0001663_abnormal_digestive_system | 0.61108252 |
| 121 | MP0000689_abnormal_spleen_morphology | 0.59149579 |
| 122 | MP0001324_abnormal_eye_pigmentation | 0.59108776 |
| 123 | MP0004782_abnormal_surfactant_physiolog | 0.58858056 |
| 124 | MP0000579_abnormal_nail_morphology | 0.58632701 |
| 125 | MP0005464_abnormal_platelet_physiology | 0.57149373 |
| 126 | MP0002136_abnormal_kidney_physiology | 0.55499990 |
| 127 | MP0001853_heart_inflammation | 0.55077632 |
| 128 | MP0002928_abnormal_bile_duct | 0.54936469 |
| 129 | MP0002060_abnormal_skin_morphology | 0.50868602 |
| 130 | MP0003453_abnormal_keratinocyte_physiol | 0.50824603 |
| 131 | MP0001243_abnormal_dermal_layer | 0.50812808 |
| 132 | MP0005187_abnormal_penis_morphology | 0.50660983 |
| 133 | MP0003638_abnormal_response/metabolism_ | 0.50512533 |
| 134 | MP0001881_abnormal_mammary_gland | 0.49826316 |
| 135 | MP0002090_abnormal_vision | 0.49115355 |
| 136 | MP0004130_abnormal_muscle_cell | 0.48101661 |
| 137 | MP0009384_cardiac_valve_regurgitation | 0.47859425 |
| 138 | MP0010234_abnormal_vibrissa_follicle | 0.47823102 |
| 139 | MP0000639_abnormal_adrenal_gland | 0.47751170 |
| 140 | MP0001845_abnormal_inflammatory_respons | 0.44896168 |
| 141 | MP0005266_abnormal_metabolism | 0.44252211 |
| 142 | MP0004947_skin_inflammation | 0.43954960 |
| 143 | MP0005395_other_phenotype | 0.43859976 |
| 144 | MP0000685_abnormal_immune_system | 0.43241389 |
| 145 | MP0005253_abnormal_eye_physiology | 0.41982359 |
| 146 | MP0005166_decreased_susceptibility_to | 0.41607665 |
| 147 | MP0005535_abnormal_body_temperature | 0.40860101 |
| 148 | MP0005448_abnormal_energy_balance | 0.40462175 |
| 149 | MP0003724_increased_susceptibility_to | 0.39900559 |
| 150 | MP0003690_abnormal_glial_cell | 0.38656769 |
| 151 | MP0000427_abnormal_hair_cycle | 0.38502629 |
| 152 | MP0005023_abnormal_wound_healing | 0.38199686 |
| 153 | MP0003300_gastrointestinal_ulcer | 0.37194315 |
| 154 | MP0005195_abnormal_posterior_eye | 0.37108009 |
| 155 | MP0005197_abnormal_uvea_morphology | 0.36328268 |
| 156 | MP0002168_other_aberrant_phenotype | 0.36286007 |
| 157 | MP0006036_abnormal_mitochondrial_physio | 0.35928513 |
| 158 | MP0008873_increased_physiological_sensi | 0.35763482 |
| 159 | MP0002098_abnormal_vibrissa_morphology | 0.32752212 |
| 160 | MP0001216_abnormal_epidermal_layer | 0.32448181 |
| 161 | MP0009115_abnormal_fat_cell | 0.32351334 |
| 162 | MP0002135_abnormal_kidney_morphology | 0.32250902 |
| 163 | MP0009672_abnormal_birth_weight | 0.31616051 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.47418603 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 7.23595352 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.97445108 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.55962885 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.54462958 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.29172577 |
| 7 | Xanthomatosis (HP:0000991) | 6.22214282 |
| 8 | Complement deficiency (HP:0004431) | 5.35379164 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.34969628 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.79341720 |
| 11 | Joint hemorrhage (HP:0005261) | 4.69229316 |
| 12 | Abnormality of the common coagulation pathway (HP:0010990) | 4.62377332 |
| 13 | Epidermoid cyst (HP:0200040) | 4.46039287 |
| 14 | Hyperammonemia (HP:0001987) | 4.38255512 |
| 15 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.36662360 |
| 16 | Hypoalphalipoproteinemia (HP:0003233) | 4.24829671 |
| 17 | Hyperglycinemia (HP:0002154) | 4.21267173 |
| 18 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.17582912 |
| 19 | Stomatitis (HP:0010280) | 4.16219756 |
| 20 | Fat malabsorption (HP:0002630) | 4.14967810 |
| 21 | Abnormality of methionine metabolism (HP:0010901) | 4.14332941 |
| 22 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.13335811 |
| 23 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.13335811 |
| 24 | Abnormality of glycolipid metabolism (HP:0010969) | 4.13335811 |
| 25 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.13330760 |
| 26 | Optic neuritis (HP:0100653) | 4.09056569 |
| 27 | Retrobulbar optic neuritis (HP:0100654) | 4.09056569 |
| 28 | Abnormality of complement system (HP:0005339) | 4.01779727 |
| 29 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.91798932 |
| 30 | Ketosis (HP:0001946) | 3.88306242 |
| 31 | Abnormality of the intrinsic pathway (HP:0010989) | 3.80021574 |
| 32 | Hyperglycinuria (HP:0003108) | 3.72954704 |
| 33 | Conjugated hyperbilirubinemia (HP:0002908) | 3.70637914 |
| 34 | Abnormality of glycine metabolism (HP:0010895) | 3.64741369 |
| 35 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.64741369 |
| 36 | Orchitis (HP:0100796) | 3.64152745 |
| 37 | Hypoglycemic coma (HP:0001325) | 3.63704152 |
| 38 | Hypercholesterolemia (HP:0003124) | 3.61069412 |
| 39 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.60209955 |
| 40 | Pigmentary retinal degeneration (HP:0001146) | 3.35149003 |
| 41 | Vacuolated lymphocytes (HP:0001922) | 3.30783085 |
| 42 | Disinhibition (HP:0000734) | 3.29719909 |
| 43 | Thyroiditis (HP:0100646) | 3.28654005 |
| 44 | Hematochezia (HP:0002573) | 3.25169396 |
| 45 | Myocardial infarction (HP:0001658) | 3.22937670 |
| 46 | Steatorrhea (HP:0002570) | 3.16122776 |
| 47 | Hyperbilirubinemia (HP:0002904) | 3.11860874 |
| 48 | Chorioretinal atrophy (HP:0000533) | 3.11263462 |
| 49 | Myositis (HP:0100614) | 3.05794886 |
| 50 | Hepatocellular carcinoma (HP:0001402) | 3.05000249 |
| 51 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.03351542 |
| 52 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.00998727 |
| 53 | Spontaneous abortion (HP:0005268) | 2.99604830 |
| 54 | Methylmalonic acidemia (HP:0002912) | 2.95657328 |
| 55 | Abnormality of nucleobase metabolism (HP:0010932) | 2.91790684 |
| 56 | Hypochromic microcytic anemia (HP:0004840) | 2.86188383 |
| 57 | Keratoconjunctivitis (HP:0001096) | 2.85460820 |
| 58 | Parakeratosis (HP:0001036) | 2.81985536 |
| 59 | Abnormality of serum amino acid levels (HP:0003112) | 2.78284478 |
| 60 | Vascular calcification (HP:0004934) | 2.77721634 |
| 61 | Severe combined immunodeficiency (HP:0004430) | 2.74734257 |
| 62 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.74071598 |
| 63 | Delayed CNS myelination (HP:0002188) | 2.74056514 |
| 64 | Mesangial abnormality (HP:0001966) | 2.73009352 |
| 65 | Systemic lupus erythematosus (HP:0002725) | 2.72683733 |
| 66 | Abolished electroretinogram (ERG) (HP:0000550) | 2.68711870 |
| 67 | Glomerulonephritis (HP:0000099) | 2.68145253 |
| 68 | Skin nodule (HP:0200036) | 2.67852398 |
| 69 | Intestinal atresia (HP:0011100) | 2.67301953 |
| 70 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.67030128 |
| 71 | Keratoconjunctivitis sicca (HP:0001097) | 2.64191892 |
| 72 | 3-Methylglutaconic aciduria (HP:0003535) | 2.60764257 |
| 73 | Ketoacidosis (HP:0001993) | 2.59204118 |
| 74 | B lymphocytopenia (HP:0010976) | 2.58265792 |
| 75 | Esophageal varix (HP:0002040) | 2.58224205 |
| 76 | Septo-optic dysplasia (HP:0100842) | 2.58131298 |
| 77 | Abnormality of purine metabolism (HP:0004352) | 2.57581049 |
| 78 | Abnormality of B cell number (HP:0010975) | 2.53617083 |
| 79 | Pancreatic fibrosis (HP:0100732) | 2.53069652 |
| 80 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 2.52197055 |
| 81 | Acanthocytosis (HP:0001927) | 2.48514601 |
| 82 | Cardiovascular calcification (HP:0011915) | 2.47963702 |
| 83 | Combined immunodeficiency (HP:0005387) | 2.45363166 |
| 84 | True hermaphroditism (HP:0010459) | 2.42244593 |
| 85 | Pancreatic cysts (HP:0001737) | 2.39877390 |
| 86 | Metabolic acidosis (HP:0001942) | 2.39709018 |
| 87 | Hypoplastic pelvis (HP:0008839) | 2.38568367 |
| 88 | Mitral stenosis (HP:0001718) | 2.37978469 |
| 89 | Gingival bleeding (HP:0000225) | 2.36005894 |
| 90 | Short hallux (HP:0010109) | 2.33611055 |
| 91 | Methylmalonic aciduria (HP:0012120) | 2.32887807 |
| 92 | Congenital sensorineural hearing impairment (HP:0008527) | 2.32374824 |
| 93 | Molar tooth sign on MRI (HP:0002419) | 2.32150478 |
| 94 | Abnormality of midbrain morphology (HP:0002418) | 2.32150478 |
| 95 | Gout (HP:0001997) | 2.32110368 |
| 96 | Hypoglycemic seizures (HP:0002173) | 2.31355717 |
| 97 | Congenital stationary night blindness (HP:0007642) | 2.30364290 |
| 98 | Abnormality of the phalanges of the 5th finger (HP:0004213) | 2.30258889 |
| 99 | Spastic diplegia (HP:0001264) | 2.29243969 |
| 100 | Abnormal gallbladder morphology (HP:0012437) | 2.28513304 |
| 101 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 2.27693250 |
| 102 | Short 1st metacarpal (HP:0010034) | 2.27693250 |
| 103 | Lethargy (HP:0001254) | 2.26314244 |
| 104 | Dysostosis multiplex (HP:0000943) | 2.25679338 |
| 105 | Inappropriate behavior (HP:0000719) | 2.25619925 |
| 106 | Thrombophlebitis (HP:0004418) | 2.25249039 |
| 107 | Cholelithiasis (HP:0001081) | 2.24400181 |
| 108 | Pulmonary infiltrates (HP:0002113) | 2.23469711 |
| 109 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.22948692 |
| 110 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.21409321 |
| 111 | Agitation (HP:0000713) | 2.19711565 |
| 112 | T lymphocytopenia (HP:0005403) | 2.17840172 |
| 113 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.17061317 |
| 114 | Dicarboxylic aciduria (HP:0003215) | 2.17061317 |
| 115 | Vitreoretinal degeneration (HP:0000655) | 2.16812772 |
| 116 | Abnormality of vitamin B metabolism (HP:0004340) | 2.15330082 |
| 117 | Irritability (HP:0000737) | 2.15156091 |
| 118 | Nuclear cataract (HP:0100018) | 2.14196667 |
| 119 | Autoimmune thrombocytopenia (HP:0001973) | 2.13962412 |
| 120 | Hypothermia (HP:0002045) | 2.13876212 |
| 121 | Gangrene (HP:0100758) | 2.13278116 |
| 122 | Adactyly (HP:0009776) | 2.13032513 |
| 123 | Malnutrition (HP:0004395) | 2.12341501 |
| 124 | Pendular nystagmus (HP:0012043) | 2.12001069 |
| 125 | Neonatal onset (HP:0003623) | 2.11434019 |
| 126 | Metaphyseal irregularity (HP:0003025) | 2.11101162 |
| 127 | Nephritis (HP:0000123) | 2.10417769 |
| 128 | Menorrhagia (HP:0000132) | 2.08239458 |
| 129 | Abnormality of T cell number (HP:0011839) | 2.07972588 |
| 130 | Pancreatitis (HP:0001733) | 2.06589007 |
| 131 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.06530101 |
| 132 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.04325915 |
| 133 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.04325915 |
| 134 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.04325915 |
| 135 | Aplasia/Hypoplasia of the middle phalanx of the 5th finger (HP:0009161) | 2.04172510 |
| 136 | Short tibia (HP:0005736) | 2.04135826 |
| 137 | Hydroxyprolinuria (HP:0003080) | 2.03579268 |
| 138 | Abnormality of proline metabolism (HP:0010907) | 2.03579268 |
| 139 | Leukocytosis (HP:0001974) | 2.03128647 |
| 140 | Enlarged kidneys (HP:0000105) | 2.02602640 |
| 141 | Polyneuropathy (HP:0001271) | 2.02403541 |
| 142 | Hemorrhage of the eye (HP:0011885) | 2.01393409 |
| 143 | Mutism (HP:0002300) | 2.00766732 |
| 144 | Abnormality of macrophages (HP:0004311) | 2.00219643 |
| 145 | Sensorimotor neuropathy (HP:0007141) | 1.99966851 |
| 146 | IgG deficiency (HP:0004315) | 1.99941632 |
| 147 | Short femoral neck (HP:0100864) | 1.97058369 |
| 148 | Abnormality of vitamin metabolism (HP:0100508) | 1.96455231 |
| 149 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.95884600 |
| 150 | Recurrent bacterial skin infections (HP:0005406) | 1.95078276 |
| 151 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.94645056 |
| 152 | Mucopolysacchariduria (HP:0008155) | 1.94645056 |
| 153 | Cerebral edema (HP:0002181) | 1.94569089 |
| 154 | Asplenia (HP:0001746) | 1.94289174 |
| 155 | Poikilocytosis (HP:0004447) | 1.94197862 |
| 156 | Amyloidosis (HP:0011034) | 1.94116255 |
| 157 | Anorexia (HP:0002039) | 1.93953372 |
| 158 | Abnormal cartilage morphology (HP:0002763) | 1.92236636 |
| 159 | Abnormality of the 1st metacarpal (HP:0010009) | 1.91457526 |
| 160 | Albinism (HP:0001022) | 1.91382878 |
| 161 | Abnormality of eosinophils (HP:0001879) | 1.89939410 |
| 162 | Rickets (HP:0002748) | 1.89850908 |
| 163 | Cholecystitis (HP:0001082) | 1.89705473 |
| 164 | Abnormal gallbladder physiology (HP:0012438) | 1.89705473 |
| 165 | Abnormality of the costochondral junction (HP:0000919) | 1.89592053 |
| 166 | Nephronophthisis (HP:0000090) | 1.88466836 |
| 167 | Renal cortical cysts (HP:0000803) | 1.88321613 |
| 168 | Hyperglycemia (HP:0003074) | 1.88004869 |
| 169 | Encephalitis (HP:0002383) | 1.87808389 |
| 170 | Abnormality of the gallbladder (HP:0005264) | 1.86540944 |
| 171 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.86398663 |
| 172 | Episodic fever (HP:0001954) | 1.84374188 |
| 173 | Mesomelia (HP:0003027) | 1.83708537 |
| 174 | Fused cervical vertebrae (HP:0002949) | 1.83565854 |
| 175 | Opisthotonus (HP:0002179) | 1.83041413 |
| 176 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.82991218 |
| 177 | Aplasia/Hypoplasia of the phalanges of the 5th finger (HP:0009376) | 1.82580028 |
| 178 | Progressive inability to walk (HP:0002505) | 1.82284726 |
| 179 | Polyphagia (HP:0002591) | 1.81921633 |
| 180 | Abnormality of iron homeostasis (HP:0011031) | 1.81915571 |
| 181 | Brushfield spots (HP:0001088) | 1.81375432 |
| 182 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.80730335 |
| 183 | Autoimmune hemolytic anemia (HP:0001890) | 1.80519065 |
| 184 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.78778232 |
| 185 | Late onset (HP:0003584) | 1.78684510 |
| 186 | Pulmonary embolism (HP:0002204) | 1.78012327 |
| 187 | Nausea (HP:0002018) | 1.77268302 |
| 188 | Vomiting (HP:0002013) | 1.77101947 |
| 189 | Recurrent fungal infections (HP:0002841) | 1.76882355 |
| 190 | Elevated hepatic transaminases (HP:0002910) | 1.73295510 |
| 191 | Generalized aminoaciduria (HP:0002909) | 1.69818824 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.02389807 |
| 2 | FGFR4 | 4.47724651 |
| 3 | SIK1 | 4.07616753 |
| 4 | ERN1 | 3.91835262 |
| 5 | ADRBK2 | 3.61749728 |
| 6 | ACVR1B | 3.59387256 |
| 7 | GRK7 | 3.47322192 |
| 8 | BMPR1B | 3.23924143 |
| 9 | WNK3 | 2.88800819 |
| 10 | ERBB4 | 2.65174682 |
| 11 | MAP4K2 | 2.54347618 |
| 12 | TAOK3 | 2.43339566 |
| 13 | DDR2 | 2.26574198 |
| 14 | MST1R | 2.24849632 |
| 15 | LATS1 | 2.20996935 |
| 16 | INSRR | 2.19598640 |
| 17 | PBK | 2.17893914 |
| 18 | PKN2 | 2.13828445 |
| 19 | TYK2 | 2.13517184 |
| 20 | MAP3K14 | 1.98727587 |
| 21 | FRK | 1.88609244 |
| 22 | MST4 | 1.87015506 |
| 23 | TNIK | 1.86816435 |
| 24 | GRK1 | 1.86339473 |
| 25 | TRIB3 | 1.83494360 |
| 26 | PTK6 | 1.73470610 |
| 27 | MATK | 1.65875166 |
| 28 | FGFR2 | 1.59996409 |
| 29 | NME2 | 1.59193572 |
| 30 | KDR | 1.58833611 |
| 31 | NEK9 | 1.58603877 |
| 32 | PLK2 | 1.56191409 |
| 33 | FLT3 | 1.53267404 |
| 34 | TBK1 | 1.51543851 |
| 35 | MAP3K10 | 1.51447477 |
| 36 | PIK3CG | 1.46348642 |
| 37 | BMPR2 | 1.45799894 |
| 38 | JAK1 | 1.45499315 |
| 39 | MAPK11 | 1.43277470 |
| 40 | TRIM28 | 1.42218831 |
| 41 | DYRK1B | 1.39772609 |
| 42 | ERBB3 | 1.35651908 |
| 43 | JAK2 | 1.35258140 |
| 44 | EIF2AK3 | 1.35033797 |
| 45 | MKNK2 | 1.34411745 |
| 46 | FGFR3 | 1.30026932 |
| 47 | EPHA3 | 1.29001651 |
| 48 | MOS | 1.28097173 |
| 49 | STK38L | 1.27119311 |
| 50 | MAP3K3 | 1.24312848 |
| 51 | MAP2K4 | 1.16482630 |
| 52 | MAP3K7 | 1.16423993 |
| 53 | FGR | 1.12857507 |
| 54 | PAK3 | 1.11060307 |
| 55 | IKBKE | 1.05598694 |
| 56 | CDK6 | 1.05434322 |
| 57 | ERBB2 | 1.04679688 |
| 58 | IRAK4 | 1.03036921 |
| 59 | MAP4K1 | 0.98675427 |
| 60 | TGFBR2 | 0.97262656 |
| 61 | GRK6 | 0.96431369 |
| 62 | ZAK | 0.94440856 |
| 63 | CLK1 | 0.94395156 |
| 64 | PRKAA2 | 0.94094771 |
| 65 | ABL2 | 0.91868679 |
| 66 | CHUK | 0.89251137 |
| 67 | LYN | 0.88205380 |
| 68 | ITK | 0.88140764 |
| 69 | MAP2K3 | 0.87324735 |
| 70 | EPHB1 | 0.85770956 |
| 71 | KIT | 0.85360897 |
| 72 | NLK | 0.82723658 |
| 73 | JAK3 | 0.82309170 |
| 74 | CSK | 0.81627714 |
| 75 | RIPK1 | 0.81338054 |
| 76 | MKNK1 | 0.81331780 |
| 77 | CAMK1D | 0.79159402 |
| 78 | GSK3A | 0.78543717 |
| 79 | MAP2K6 | 0.78502946 |
| 80 | IRAK3 | 0.77224826 |
| 81 | IRAK2 | 0.77052577 |
| 82 | PRKCZ | 0.76518769 |
| 83 | CSNK1G1 | 0.74844189 |
| 84 | MET | 0.74346073 |
| 85 | MAPK7 | 0.74280765 |
| 86 | MAPK12 | 0.73866223 |
| 87 | DAPK2 | 0.71602490 |
| 88 | MAPK4 | 0.71104623 |
| 89 | CSNK1G2 | 0.67286114 |
| 90 | PLK3 | 0.66808599 |
| 91 | CSNK1G3 | 0.66065873 |
| 92 | SGK3 | 0.65697194 |
| 93 | SYK | 0.63807173 |
| 94 | EPHB2 | 0.63532076 |
| 95 | PLK4 | 0.62173649 |
| 96 | EIF2AK2 | 0.61830880 |
| 97 | ZAP70 | 0.61356139 |
| 98 | TAOK1 | 0.60488953 |
| 99 | EPHA2 | 0.59887615 |
| 100 | IKBKB | 0.58224106 |
| 101 | DYRK3 | 0.57966757 |
| 102 | TAF1 | 0.57613241 |
| 103 | LCK | 0.57460923 |
| 104 | PIM2 | 0.57026836 |
| 105 | PRKCE | 0.56605153 |
| 106 | MAP3K4 | 0.56389161 |
| 107 | MTOR | 0.55822942 |
| 108 | CAMKK2 | 0.55354810 |
| 109 | STK10 | 0.55181079 |
| 110 | PRKCQ | 0.54987586 |
| 111 | PTK2 | 0.54233757 |
| 112 | PRKACG | 0.54123608 |
| 113 | CDK4 | 0.53652277 |
| 114 | TYRO3 | 0.52257059 |
| 115 | CDC42BPA | 0.52071551 |
| 116 | TXK | 0.51980246 |
| 117 | TIE1 | 0.51925567 |
| 118 | FGFR1 | 0.51667878 |
| 119 | STK16 | 0.51496717 |
| 120 | NUAK1 | 0.50961471 |
| 121 | IRAK1 | 0.50801479 |
| 122 | SGK2 | 0.50587891 |
| 123 | STK3 | 0.50510970 |
| 124 | ADRBK1 | 0.50203235 |
| 125 | MAP3K5 | 0.49329826 |
| 126 | MAP3K11 | 0.48469012 |
| 127 | IGF1R | 0.48242420 |
| 128 | NTRK2 | 0.48060560 |
| 129 | PRKAA1 | 0.48028209 |
| 130 | PIM1 | 0.47168608 |
| 131 | PRKCG | 0.46961639 |
| 132 | WNK4 | 0.46541226 |
| 133 | PINK1 | 0.46441660 |
| 134 | INSR | 0.46364490 |
| 135 | TAOK2 | 0.45272269 |
| 136 | MARK3 | 0.44693446 |
| 137 | TEC | 0.44353649 |
| 138 | RPS6KA4 | 0.44235131 |
| 139 | BMX | 0.44081965 |
| 140 | CSNK1A1L | 0.43542212 |
| 141 | MAPK13 | 0.43466548 |
| 142 | FER | 0.42586760 |
| 143 | TGFBR1 | 0.42015153 |
| 144 | LRRK2 | 0.41284809 |
| 145 | BLK | 0.39542453 |
| 146 | TLK1 | 0.38789064 |
| 147 | EGFR | 0.36056221 |
| 148 | PDGFRA | 0.34246166 |
| 149 | PTK2B | 0.33138651 |
| 150 | CSF1R | 0.32489067 |
| 151 | CAMK2G | 0.31415912 |
| 152 | HCK | 0.31204958 |
| 153 | CDK8 | 0.30745481 |
| 154 | RET | 0.29433208 |
| 155 | CDK12 | 0.28510169 |
| 156 | AKT3 | 0.28144106 |
| 157 | ABL1 | 0.27565069 |
| 158 | MAPK3 | 0.27079768 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.55142284 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.75116154 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.66245816 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.33379356 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.15789426 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.89938325 |
| 7 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.69948007 |
| 8 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.64360511 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.62184110 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.54946329 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.49514470 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.46602933 |
| 13 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.40021561 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.26916179 |
| 15 | Allograft rejection_Homo sapiens_hsa05330 | 2.22586403 |
| 16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.21576764 |
| 17 | Asthma_Homo sapiens_hsa05310 | 2.19609710 |
| 18 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.12761659 |
| 19 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.09910987 |
| 20 | Malaria_Homo sapiens_hsa05144 | 2.09559107 |
| 21 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.06689024 |
| 22 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.05111412 |
| 23 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.02299164 |
| 24 | Peroxisome_Homo sapiens_hsa04146 | 1.97702968 |
| 25 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.96275392 |
| 26 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.95799136 |
| 27 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.94992599 |
| 28 | Pertussis_Homo sapiens_hsa05133 | 1.94614027 |
| 29 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.92580362 |
| 30 | Histidine metabolism_Homo sapiens_hsa00340 | 1.90770104 |
| 31 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.90759344 |
| 32 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.89902737 |
| 33 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.89576248 |
| 34 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.89171974 |
| 35 | Retinol metabolism_Homo sapiens_hsa00830 | 1.87243946 |
| 36 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.82607330 |
| 37 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.79166994 |
| 38 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.77029631 |
| 39 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.76509673 |
| 40 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.68798728 |
| 41 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.68324875 |
| 42 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.66004104 |
| 43 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.64686321 |
| 44 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.64038868 |
| 45 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.64004282 |
| 46 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.63861907 |
| 47 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.60700209 |
| 48 | Protein export_Homo sapiens_hsa03060 | 1.51640982 |
| 49 | Lysosome_Homo sapiens_hsa04142 | 1.46167821 |
| 50 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.45821889 |
| 51 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.44650553 |
| 52 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.42876865 |
| 53 | Bile secretion_Homo sapiens_hsa04976 | 1.42390099 |
| 54 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.40934084 |
| 55 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.39427104 |
| 56 | Other glycan degradation_Homo sapiens_hsa00511 | 1.37224977 |
| 57 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.33197121 |
| 58 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.33179858 |
| 59 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.32253632 |
| 60 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.31434326 |
| 61 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.27643671 |
| 62 | Leishmaniasis_Homo sapiens_hsa05140 | 1.26462604 |
| 63 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.25767713 |
| 64 | Tuberculosis_Homo sapiens_hsa05152 | 1.24250377 |
| 65 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.23448549 |
| 66 | ABC transporters_Homo sapiens_hsa02010 | 1.23422062 |
| 67 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.22255895 |
| 68 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.21994350 |
| 69 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.20953909 |
| 70 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.19803573 |
| 71 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.17756512 |
| 72 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.17749602 |
| 73 | Phototransduction_Homo sapiens_hsa04744 | 1.16536001 |
| 74 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.15751077 |
| 75 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.11117813 |
| 76 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.05311098 |
| 77 | Carbon metabolism_Homo sapiens_hsa01200 | 1.00583216 |
| 78 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.00241263 |
| 79 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.98161060 |
| 80 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.94358458 |
| 81 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.93114089 |
| 82 | Measles_Homo sapiens_hsa05162 | 0.93005706 |
| 83 | Lysine degradation_Homo sapiens_hsa00310 | 0.90643380 |
| 84 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.87724959 |
| 85 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.86298145 |
| 86 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.85798656 |
| 87 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.84300444 |
| 88 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.82499094 |
| 89 | Sulfur relay system_Homo sapiens_hsa04122 | 0.81967580 |
| 90 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.81916066 |
| 91 | Influenza A_Homo sapiens_hsa05164 | 0.81432656 |
| 92 | Mineral absorption_Homo sapiens_hsa04978 | 0.81424263 |
| 93 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.81027493 |
| 94 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.77382635 |
| 95 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.75430418 |
| 96 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.73963757 |
| 97 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.73420474 |
| 98 | Proteasome_Homo sapiens_hsa03050 | 0.73003145 |
| 99 | Salmonella infection_Homo sapiens_hsa05132 | 0.72675557 |
| 100 | Basal transcription factors_Homo sapiens_hsa03022 | 0.72662886 |
| 101 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.71239591 |
| 102 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.70148410 |
| 103 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.66718266 |
| 104 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.63910453 |
| 105 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.63224319 |
| 106 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.58841612 |
| 107 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.57315205 |
| 108 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.55429381 |
| 109 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.52363230 |
| 110 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.50844466 |
| 111 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.50206482 |
| 112 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.49275428 |
| 113 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.48922994 |
| 114 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.48738233 |
| 115 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.48095250 |
| 116 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.42218327 |
| 117 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.40475841 |
| 118 | * Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.39704234 |
| 119 | Metabolic pathways_Homo sapiens_hsa01100 | 0.36148218 |
| 120 | Phagosome_Homo sapiens_hsa04145 | 0.34452171 |
| 121 | Prion diseases_Homo sapiens_hsa05020 | 0.32183638 |
| 122 | Insulin resistance_Homo sapiens_hsa04931 | 0.29666676 |
| 123 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.27180298 |
| 124 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.25200218 |
| 125 | Galactose metabolism_Homo sapiens_hsa00052 | 0.22120037 |
| 126 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.21391299 |
| 127 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.19101613 |
| 128 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.17320595 |
| 129 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.12253389 |
| 130 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.04521968 |
| 131 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.03624317 |
| 132 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.03093969 |
| 133 | Legionellosis_Homo sapiens_hsa05134 | -0.2071011 |
| 134 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | -0.2037004 |
| 135 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1968303 |
| 136 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1888916 |
| 137 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1853697 |
| 138 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1827991 |
| 139 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | -0.1792020 |
| 140 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1733456 |
| 141 | Bladder cancer_Homo sapiens_hsa05219 | -0.1639481 |
| 142 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1600345 |
| 143 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1576542 |
| 144 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1561608 |
| 145 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | -0.1528595 |
| 146 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | -0.1453838 |
| 147 | Amoebiasis_Homo sapiens_hsa05146 | -0.1249727 |
| 148 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.1224260 |
| 149 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1190111 |
| 150 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1086638 |
| 151 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1022485 |
| 152 | Hepatitis C_Homo sapiens_hsa05160 | -0.0629879 |

